DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
DarioHealth Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.49−0.33 (-6.85%)
Close on Oct 19, 2026
- Market cap
- $41.95M
- P/E (TTM)
- 1.1
- Dividend yield
- –
Share price
−$8.54 (−65.54%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
DarioHealth Corp. saw revenue fall 22.6% to $21.00M over the twelve months to Jun 30, 2026. Free cash flow was -$25.48M.
Revenue
$21.00M
-22.6% vs. a year earlier
Operating income
-$31.83M
TTM Q2 2026
Free cash flow
-$25.48M
TTM Q2 2026
EPS, diluted
$3.92
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $41.95M
- P/E ratio
- 1.1
- Price to sales
- 2.00
- Price to book
- 0.76
- Dividend yield
- –
- Free cash flow yield
- -60.74%
Fundamentals
- Revenue
- $21.00M
- Net income
- -$35.67M
- EPS, diluted
- $3.92
- Free cash flow
- -$25.48M
- Book value per share
- $5.90
- Diluted shares
- 9M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$21.00M-22.6% YoY
Gross profit
$12.21M-18.2% YoY
Operating income
-$31.83M
Net income
-$35.67M
EPS, diluted
$3.92
Free cash flow
-$25.48M
Reported periodTrailing twelve months